Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

I-mab Biopharma Us Limited

Clinical trials sponsored by I-mab Biopharma Us Limited, explained in plain language.

I-Mab Biopharma US Limited IMAB NASDAQ

A biopharmaceutical company developing immunotherapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Completed 1

Experimental combo shows promise in Hard-to-Treat cancers

Disease control Completed

This study tested a new drug (TJ004309) combined with an approved immunotherapy (atezolizumab) in 25 people with advanced ovarian, head and neck, lung, gastrointestinal, or triple-negative breast cancers. The goal was to see if the combination could shrink tumors. Participants ha…

Phase: PHASE2 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC